title: Fludarabine combination therapy for follicular lymphoma followed by acute myeloid leukemia: two further case records.
authors.forename: P
authors.initials: P
authors.lastname: Bernardeschi
authors.forename: G
authors.initials: G
authors.lastname: Fiorentini
authors.forename: P
authors.initials: P
authors.lastname: Dentico
authors.forename: S
authors.initials: S
authors.lastname: Rossi
authors.forename: G
authors.initials: G
authors.lastname: Turrisi
authors.forename: A
authors.initials: A
authors.lastname: Del Conte
authors.forename: P G
authors.initials: PG
authors.lastname: Giannessi
authors.forename: G
authors.initials: G
authors.lastname: Giustarini
authors.forename: I
authors.initials: I
authors.lastname: Montenora
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced* / Q000473:pathology / Q000628:therapy; D008224:Lymphoma, Follicular / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D016609:Neoplasms, Second Primary / Q000139:chemically induced / Q000473:pathology / Q000628:therapy; D014740:Vidarabine / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D014740:Vidarabine; C024352:fludarabine